10-Q: UNFI Swings to Profit Amidst Strategic Overhaul, Debt Reduction

Sentiment:

Quarterly Report


United Natural Foods, Inc. reported a significant turnaround in Q3 fiscal 2026, achieving net income and increased Adjusted EBITDA despite overall sales declines in its Conventional and Retail segments.

Better than expectedNet income attributable to UNFI turned positive at $33 million in Q3 fiscal 2026, compared to a net loss of $7 million in Q3 fiscal 2025.Operating income significantly increased to $66 million in Q3 fiscal 2026 from $15 million in Q3 fiscal 2025.Adjusted EBITDA rose to $183 million in Q3 fiscal 2026 from $157 million in Q3 fiscal 2025.Gross profit rate improved to 13.6% from 13.4%.Operating expenses decreased by $71 million, partly due to cybersecurity insurance proceeds and cost-saving initiatives.

Summary

  • Net income attributable to United Natural Foods, Inc. was $33 million ($0.52 diluted EPS) for Q3 fiscal 2026, a substantial improvement from a net loss of $7 million ($0.12 diluted EPS) in Q3 fiscal 2025.
  • Operating income surged to $66 million in Q3 fiscal 2026, up from $15 million in the prior year's quarter.
  • Adjusted EBITDA increased by $26 million to $183 million in Q3 fiscal 2026, compared to $157 million in Q3 fiscal 2025.
  • Consolidated net sales decreased by 4.2% to $7,723 million in Q3 fiscal 2026 from $8,059 million in Q3 fiscal 2025.
  • Natural segment net sales grew by 4.4% to $4,331 million in Q3 fiscal 2026, driven by inflation and a less than 1% increase in unit volumes.
  • Conventional segment net sales declined by 13.6% to $2,877 million in Q3 fiscal 2026, primarily due to a mid-teens decline in unit volumes, including impacts from network optimization.
  • Retail segment net sales decreased by 10.1% to $515 million in Q3 fiscal 2026, attributed to store closures and a 4.4% decrease in identical store sales.
  • Gross profit as a percentage of net sales improved to 13.6% in Q3 fiscal 2026 from 13.4% in Q3 fiscal 2025, driven by network optimization and customer mix.
  • Operating expenses decreased by $71 million, or 6.9%, in Q3 fiscal 2026, benefiting from $20 million in cybersecurity insurance proceeds and cost-saving initiatives.
  • Total debt decreased by $199 million to $1,663 million as of May 2, 2026, from $1,862 million as of August 2, 2025.
  • Total liquidity as of May 2, 2026, was $1,245 million, consisting of $1,202 million in unused ABL credit and $43 million in cash and cash equivalents.
  • Year-to-date fiscal 2026, the company repurchased 824,855 shares of common stock for $29 million, with $109 million remaining authorized under the 2022 Repurchase Program.
  • The company reached a $23.4 million settlement for opioid-related lawsuits and a $39 million settlement for a securities class action, with the latter funded by insurers.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive report, demonstrating a significant turnaround in profitability and effective cost management, despite overall sales declines in certain segments. The debt reduction and strategic focus on network optimization are favorable.

Positives

  • Net income attributable to UNFI turned positive at $33 million in Q3 fiscal 2026, compared to a net loss of $7 million in Q3 fiscal 2025.
  • Operating income significantly increased to $66 million in Q3 fiscal 2026 from $15 million in Q3 fiscal 2025, reflecting improved operational efficiency.
  • Adjusted EBITDA rose by $26 million to $183 million in Q3 fiscal 2026 and by $93 million to $529 million year-to-date fiscal 2026.
  • The gross profit rate improved to 13.6% in Q3 fiscal 2026, driven by positive impacts from network optimization actions and customer mix.
  • Operating expenses decreased by $71 million in Q3 fiscal 2026, benefiting from $20 million in cybersecurity insurance proceeds and cost-saving initiatives.
  • The Natural segment demonstrated strong growth, with net sales increasing by 4.4% in Q3 and 7.1% year-to-date, including unit volume increases and new business.
  • Total debt decreased by $199 million since August 2, 2025, indicating progress in deleveraging efforts.
  • Successful settlement of opioid-related lawsuits for $23.4 million, with the liability recorded.
  • Settlement of a securities class action lawsuit for $39 million, which will be funded directly by the company's insurers.
  • The ABL Credit Facility maturity was extended to April 1, 2031, enhancing long-term liquidity.
  • Post-Q3, the company completed the sale of a surplus distribution center, expecting an $18 million gain and using proceeds for debt repayment.

Negatives

  • Overall net sales decreased by 4.2% in Q3 fiscal 2026 and 2.4% year-to-date fiscal 2026, indicating top-line challenges.
  • The Conventional segment experienced a significant decline in net sales (13.6% in Q3, 12.4% YTD), primarily due to unit volume decreases and network optimization actions, including the transition out of the Allentown, Pennsylvania distribution center.
  • The Retail segment's net sales decreased by 10.1% in Q3 and 7.9% YTD, driven by store closures and a 4.4% decline in identical store sales.
  • Total liquidity decreased by $208 million since August 2, 2025, mainly due to a reduction in the ABL borrowing base.
  • Working capital decreased by $19 million to $802 million as of May 2, 2026.
  • The company incurred $22 million in incremental costs and charges related to the Cybersecurity Incident year-to-date fiscal 2026.
  • A LIFO charge of $18 million was recognized year-to-date fiscal 2026, compared to a $5 million LIFO benefit in the prior year.
  • Asset impairment charges totaled $29 million year-to-date fiscal 2026, related to decisions to close retail store locations and discontinue operations at certain distribution centers.

Risks

  • Dependence on principal customers, which could impact sales and profitability.
  • Relatively low business margins, making the company sensitive to inflationary and deflationary pressures and intense competition.
  • Challenges in realizing the anticipated benefits of strategic initiatives, including network optimization and automation.
  • Potential for changes in relationships with suppliers, affecting product availability and costs.
  • Risks associated with technology systems, including the effectiveness of business continuity plans in response to cybersecurity incidents.
  • Labor and other workforce shortages and challenges, potentially increasing operational costs.
  • The addition or loss of significant customers or material changes to existing customer relationships.
  • Ability to grow sales, particularly of higher-margin natural and organic foods and non-food products.
  • Maintaining sufficient volume in Natural and Conventional businesses to support operating infrastructure.
  • Ability to access additional capital, which is crucial for investments and debt management.
  • Increases in healthcare, pension, and other costs under single employer and multiemployer benefit plans.
  • Potential for additional asset impairment charges due to ongoing network optimization or market changes.
  • Sensitivity to general economic conditions, including inflation, tariff policy, disposable income levels, and consumer purchasing habits.
  • Challenges in timely and successfully deploying warehouse management and transportation management systems and achieving expected efficiencies.
  • Potential for disruptions in the supply chain or distribution capabilities due to factors like lack of long-term contracts, severe weather, or labor issues.
  • Adverse decisions in, or settlement of, ongoing litigation or other proceedings (e.g., opioid, False Claims Act, prompt-pay discounts).
  • Moderated supplier promotional activity, potentially reducing forward buying opportunities.
  • Union-organizing activities that could lead to labor relations difficulties and increased costs.
  • Changes in tax laws and regulations, and actions by taxing authorities.
  • Ability to maintain food quality and safety standards.
  • Volatility in fuel costs, impacting transportation expenses.
  • Multiemployer pension plans are underfunded, and contributions could increase, with potential for withdrawal liability if contributions significantly reduce or operations cease.

Future Outlook

The company is executing a value creation strategy focused on building customer and supplier capabilities, improving effectiveness and efficiency through network optimization, managing capital spending, and optimizing its cost structure and net working capital. It expects to continue reinvesting available capital to improve free cash flow and financial leverage while reducing outstanding debt. Future network realignment, expansion, or improvements may incur incremental expenses, but efforts are underway to minimize costs and secure new business. The Retail segment will see continued investment and optimization. Fiscal 2026 capital and cloud implementation spending is projected at approximately $250 million, financed by cash from operations and ABL Credit Facility borrowings. The company anticipates reclassifying $4 million in unrealized derivative gains into interest expense over the next twelve months. No cash pension contributions are required for the SUPERVALU INC. Retirement Plan in fiscal 2026, with minor contributions expected for other defined benefit and postretirement plans. Approximately $50 million is expected to be contributed to multiemployer plans in fiscal 2026, but potential increases in healthcare expenses could arise if renegotiations are unsuccessful.

Management Comments

  • "We believe we are uniquely positioned to provide the broadest array of products, programs and services to customers throughout North America."
  • "We are executing against our value creation strategy, which seeks to build capabilities that add value to our customers and suppliers through our portfolio of products, programs, insights and services, while improving our effectiveness and efficiency."
  • "We are focused on controllable variables in several key areas: network optimization; managing annual capital spending; and optimizing our cost structure and net working capital position."
  • "We expect to continue to use available capital to re-invest in our business and are committed to improving our free cash flow and financial leverage while reducing outstanding debt."
  • "We believe we can optimize our performance and profitability through our improvement efforts, which we expect will improve our cost structure, increase sales of products and services, and position us to provide tailored, data-driven solutions to help our customers run their businesses more efficiently and expand our customer base."
  • "The U.S. economy continues to experience economic volatility, which has had, and we expect may continue to have, an impact on consumer confidence and behavior."
  • "We experienced a mix of inflation and deflation across product categories during the third quarter of fiscal 2026."
  • "The termination [of the East region supply agreement] enables us to accelerate progress toward our longer-term strategic and three-year financial objectives."
  • "We are working to both minimize future costs and obtain new business to further improve the efficiency of our distribution network."

Industry Context

StockSavvy.ai notes that UNFI's Q3 fiscal 2026 performance reflects broader industry trends, including ongoing economic volatility impacting consumer spending and a continued shift towards natural and organic products. The company's focus on network optimization and cost structure improvements is a common strategic response in the competitive, low-margin grocery distribution sector. The challenges in the Conventional and Retail segments, contrasted with growth in Natural, highlight the evolving consumer landscape and the need for distributors to adapt their offerings and operational models.

Comparison to Industry Standards

  • UNFI's shift from a net loss to a net income in Q3 fiscal 2026, alongside a significant increase in operating income and Adjusted EBITDA, indicates effective operational management and cost control, potentially outperforming some peers struggling with similar macroeconomic headwinds.
  • The 4.4% growth in Natural Net sales in Q3 fiscal 2026 demonstrates strong performance in a high-growth niche, which may exceed the growth rates of more conventional-focused distributors like Sysco (SYY) or US Foods (USFD) in their core segments.
  • The improvement in gross profit rate to 13.6% suggests successful execution of network optimization and customer mix strategies, which is a positive indicator in a sector where margin pressure is common.
  • The 4.4% decrease in Retail identical store sales indicates underperformance compared to some leading grocery chains such as Kroger (KR) or Albertsons (ACI), which often report positive comparable store sales, reflecting stronger consumer engagement or market share in their retail operations.
  • The $199 million reduction in total debt is a favorable development, positioning UNFI to improve its financial leverage in a capital-intensive industry, potentially better than some highly leveraged competitors.

Legal Proceedings

  • UNFI is named in approximately 40 Multi-District Litigation (MDL) lawsuits alleging contribution to the national opioid epidemic, with a $23.4 million settlement agreement reached in Q1 fiscal 2026, expected to be paid in Q4 fiscal 2026.
  • A complaint was filed in Minnesota state court on January 21, 2021, alleging fraud by improperly reporting inflated prescription drug prices, with a trial ready date set for April 19, 2027.
  • A qui tam action under the False Claims Act (FCA) is ongoing, alleging overcharging government healthcare programs; a jury found in favor of UNFI on March 4, 2025, but relators have appealed.
  • A putative securities class action lawsuit, filed March 29, 2023, alleging false/misleading statements, was settled for $39 million in Q3 fiscal 2026, to be funded by insurers.
  • A shareholder derivative lawsuit, filed February 6, 2026, based on similar allegations as the securities class action, was voluntarily dismissed on March 19, 2026.
  • A putative class action lawsuit, NYSM Organics LLC v. United Natural Foods, Inc., filed November 3, 2024, alleges improper prompt-pay discounts; the Massachusetts Consumer Protection Act claim was dismissed.

Stakeholder Impact

  • Shareholders are positively impacted by the return to net income, increased operating income and Adjusted EBITDA, and ongoing debt reduction efforts, though overall sales declines and pending litigation present continued risks.
  • Employees may be affected by network optimization initiatives, including distribution center closures and associated severance costs, while potential union-organizing activities pose a risk for labor relations and costs.
  • Customers may experience improved service efficiency due to network optimization, but consumer behavior shifts towards less expensive products could impact sales mix.
  • Suppliers face potential changes in relationships and moderated promotional activities, which could influence procurement terms and volumes.
  • Creditors benefit from the reduction in total debt and the extension of the ABL Credit Facility maturity, enhancing the company's financial stability and repayment capacity.

Next Steps

  • Continue network optimization initiatives, including the planned consolidation of a facility in the Central region in Q4 fiscal 2026.
  • Pay the $23.4 million liability for the opioid settlement in Q4 fiscal 2026.
  • Finalize the settlement agreement for the securities class action lawsuit.
  • Continue share repurchases under the 2022 Repurchase Program, with $109 million remaining authorized.
  • Finance fiscal 2026 capital and cloud implementation expenditures (approximately $250 million) with cash generated from operations and borrowings under the ABL Credit Facility.
  • Monitor the evolving macroeconomic and geopolitical landscape, including tariff and global trade policies and rising fuel costs.
  • Continue to evaluate the distribution center network to improve efficiency and service.
  • Continue to invest in and optimize the Retail segment, focusing on merchandising, physical facilities, technology, and operational tools.
  • Await oral argument in the appeal of the False Claims Act qui tam action.
  • Prepare for the trial in the Minnesota state court health plans fraud case, with a trial ready date set for April 19, 2027.

Key Dates

DateDescription
August 30, 2018Intercreditor Agreement dated.
October 22, 2018Term Loan Agreement dated.
July 26, 2019UNFI answered complaint in The Blackfeet Tribe of the Blackfeet Indian Reservation opioid case.
August 5, 2019Court granted one of the relators' summary judgment motions in the False Claims Act qui tam action.
July 2, 2020Court granted defendants' summary judgment motion and dismissed the False Claims Act qui tam action.
October 22, 2020Issued $500 million of unsecured 6.750% senior notes due October 15, 2028.
January 21, 2021Various health plans filed a complaint in Minnesota state court against UNFI, Albertsons Companies, LLC, and Safeway, Inc.
February 19, 2021Albertsons and Safeway removed the Minnesota state court case to Minnesota Federal District Court.
March 22, 2021Plaintiffs filed a motion to remand the Minnesota state court case.
May 20, 2021Hearing on the remand motion and motions to dismiss in the Minnesota state court case.
August 12, 2021Seventh Circuit affirmed the District Court's decision granting summary judgment in the False Claims Act qui tam action.
September 21, 2021Federal District Court remanded the Minnesota state court case to Minnesota state court.
February 1, 2022Minnesota state court denied the motion to dismiss in the health plans fraud case.
June 3, 2022Company's existing $2,730 million ABL credit facility dated.
September 21, 2022Board of Directors authorized a share repurchase program for up to $200 million.
October 7, 2022MDL Court issued an order directing the company to submit opioid dispensing and distribution data.
March 8, 2023Company received a subpoena from the Consumer Protection Division of the Maryland Attorney General's Office seeking opioid-related records.
March 29, 2023Putative securities class action lawsuit filed against the company.
May 19, 2023Company provided an initial production in response to the Maryland Attorney General's subpoena.
June 1, 2023Supreme Court reversed and vacated the lower courts judgment in the False Claims Act qui tam action and remanded the case to the Seventh Circuit.
July 27, 2023Seventh Circuit vacated the summary judgment order and remanded the False Claims Act qui tam action to the District Court.
August 22, 2023District Court set the trial date for the False Claims Act qui tam action for April 29, 2024.
October 11, 2023Company and relators filed motions for summary judgment in the False Claims Act qui tam action.
December 2023FASB issued ASU 2023-09, 'Income Taxes (Topic 740): Improvements to Income Tax Disclosures'.
December 21, 2023Defendants filed a Motion to Dismiss the securities class action.
December 29, 2023Effective date of certain interest rate swap contracts.
February 16, 2024Defendants filed a motion to reconsider partial grant of summary judgment and to continue the trial date in the False Claims Act qui tam action.
February 27, 2024Court granted the defendants' motion for a trial date continuance and vacated the April 29, 2024 trial date in the False Claims Act qui tam action.
April 24, 2024Status conference held by the MDL Court regarding opioid cases.
April 26, 2024Court denied the defendants' motion to reconsider the partial grant of summary judgment in the False Claims Act qui tam action.
May 1, 2024FILO Loans were funded.
May 20, 2024District Court heard oral argument on the pending motions for summary judgment in the False Claims Act qui tam action.
June 25, 2024Effective date of certain interest rate swap contracts.
September 13, 2024Court issued an opinion granting in part and denying in part the motion to dismiss the securities class action.
September 30, 2024Court denied both parties' motions for summary judgment on scienter and granted the relators' motion for summary judgment on materiality in the False Claims Act qui tam action.
October 28, 2024Company answered the securities class action complaint denying the allegations.
October 31, 2024Effective date of certain interest rate swap contracts.
November 3, 2024Putative class action lawsuit filed by NYSM Organics LLC against the company.
November 2024FASB issued ASU 2024-03, 'Income StatementReporting Comprehensive IncomeExpense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses'.
December 30, 2024Amended Complaint filed in the NYSM Organics LLC class action.
March 4, 2025Jury found in favor of the company in the False Claims Act qui tam action.
March 7, 2025Plaintiffs filed a motion for class certification in the securities class action.
April 1, 2025Relators filed a motion asking the District Court to alter or amend the judgment in the False Claims Act qui tam action.
April 29, 2025Company filed its response in opposition to the relators' motion in the False Claims Act qui tam action.
June 5, 2025Court dismissed the Massachusetts Consumer Protection Act claim in the NYSM Organics LLC class action.
June 13, 2025Company filed its response to the motion for class certification in the securities class action.
June 16, 2025Company filed its answer to the Amended Complaint in the NYSM Organics LLC class action.
August 2, 2025Fiscal year ended.
September 6, 2025Supply agreement with a customer in the East region terminated.
September 2025FASB issued ASU 2025-06, 'Intangibles (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software'.
October 31, 2025Court denied the relators' motions in the False Claims Act qui tam action.
November 26, 2025Relators filed a notice of appeal with the Seventh Circuit Court of Appeals in the False Claims Act qui tam action.
December 5, 2025Company filed its cross appeal in the False Claims Act qui tam action.
December 22, 2025Effective date of certain interest rate swap contracts.
December 2025FASB issued ASU 2025-11, 'Interim Reporting (Topic 270): Narrow-Scope Improvements'.
February 6, 2026Shareholder derivative lawsuit filed against the company.
February 26, 2026Company redeemed $115 million aggregate principal amount of the Senior Notes.
March 19, 2026Shareholder derivative lawsuit voluntarily dismissed.
April 1, 2026Amended and Restated Loan Agreement (ABL Credit Facility) became effective, extending maturity to April 1, 2031.
May 2, 2026End of the quarterly period.
June 4, 202660,519,140 shares of common stock outstanding.
June 9, 2026Filing date of the 10-Q report.
October 30, 2026Maturity date of certain interest rate swap contracts.
June 3, 2027Maturity date of certain interest rate swap contracts.
April 19, 2027Trial ready date for the Minnesota state court health plans fraud case.
June 30, 2028Maturity date of certain interest rate swap contracts.
October 15, 2028Maturity date of the Senior Notes.
December 29, 2028Maturity date of certain interest rate swap contracts.
April 1, 2031Maturity date of the ABL Credit Facility.
May 1, 2031Maturity date of the Term Loan Facility.

Recommendation

hold

The company demonstrated a strong turnaround in profitability and effective cost management, leading to positive net income and increased Adjusted EBITDA. Debt reduction is also a favorable sign. However, overall net sales declined, driven by weaknesses in the Conventional and Retail segments, and significant litigation remains ongoing, creating uncertainty. The positive operational improvements are balanced by these persistent challenges and the need for continued strategic execution, warranting a 'hold' recommendation for seasoned investors.

Keywords

Natural Foods, Organic Products, Grocery Distribution, Wholesale, Retail, Supply Chain, Network Optimization, Debt Reduction, Financial Performance, SEC Filing, 10-Q, Earnings, EBITDA, Liquidity, Cybersecurity, Litigation, Pension Plans, Capital Expenditures, Share Repurchase

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.